Allyx Therapeutics, Inc.
PrivateLast Round
Series A
May 4, 2026
Total Funding Raised
$11.15M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Allyx Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Grant round in October 2024.
Allyx Therapeutics, Inc. is a biotechnology company developing a first-in-class oral therapy to treat neurodegenerative diseases such as Alzheimer's and Parkinson's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allyx Therapeutics, Inc. Comparables
Compare Allyx Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spinogenix, Inc. | 85% | |
| Nura Bio | 84% | |
| Muna Therapeutics | 83% |
For institutional investors. Book with your work email.
Allyx Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 4, 2026 | ||||
| Seed Round | Feb 23, 2026 | ||||
| Grant | Oct 15, 2024 | ||||
| Early Funding | Feb 3, 2023 | ||||
| Series A | Jun 1, 2021 | ||||
Early Funding | May 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Allyx Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A, Pre Seed, Early Funding |
| NIH RADx | Grant |
| Elm Street Ventures | Series A |
| Canaan Partners | Series A |
| Life Science Angels | Series A |
| Harrington Discovery Institute | Series A |
| Spring Mountain Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
$26.4M raised in an early stage VC round.
- Feb 3, 2023
Raised $2.3M in early funding.
For institutional investors. Book with your work email.
Allyx Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Allyx Therapeutics, Inc.'s valuation, stock price, and market status.
Is Allyx Therapeutics, Inc. a public or private company?
Allyx Therapeutics, Inc. is a private company.
What is the current stock price of Allyx Therapeutics, Inc.?
Allyx Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Allyx Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Allyx Therapeutics, Inc. worth (valuation)?
Valuation information for Allyx Therapeutics, Inc. is not publicly available.
Can I buy Allyx Therapeutics, Inc. stock?
Allyx Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Allyx Therapeutics, Inc.'s last funding round?
Allyx Therapeutics, Inc.'s most recent funding round was Series A on May 4, 2026.
Who are the main investors in Allyx Therapeutics, Inc.?
Key investors in Allyx Therapeutics, Inc. include Elm Street Ventures, Spring Mountain Capital.
Will Allyx Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Allyx Therapeutics, Inc..
How can I track Allyx Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Allyx Therapeutics, Inc.'s shares on secondary markets.